TITLE

Antiretroviral Treatment Breaks Limit CD4 Count Gains and Raise Death Risk

PUB. DATE
March 2011
SOURCE
HIV Treatment ALERTS!;Mar2011, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study on the effect of antiretroviral therapy on HIV patients in Switzerland. It shows that there are fewer CD4 cells in patients who interrupted their antiretroviral therapy and they have an increased risk of death and new AIDS diseases. According to the study, the risk of a new AIDS disease rose when the overall interruption of antiretroviral therapy increased.
ACCESSION #
74447510

 

Related Articles

  • Cost-Effectiveness Analysis of Option B+ for HIV Prevention and Treatment of Mothers and Children in Malawi. Fasawe, Olufunke; Avila, Carlos; Shaffer, Nathan; Schouten, Erik; Chimbwandira, Frank; Hoos, David; Nakakeeto, Olive; De Lay, Paul // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Background: The Ministry of Health in Malawi is implementing a pragmatic and innovative approach for the management of all HIV-infected pregnant women, termed Option B+, which consists of providing life-long antiretroviral treatment, regardless of their CD4 count or clinical stage. Our...

  • HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients. Xing, Hui; Ruan, Yuhua; Li, Jingyun; Shang, Hong; Zhong, Ping; Wang, Xia; Liao, Lingjie; Li, Hanping; Zhang, Min; Xue, Yile; Wang, Zhe; Su, Bin; Liu, Wei; Dong, Yonghui; Ma, Yanling; Li, Huiqin; Qin, Guangming; Chen, Lin; Pan, Xiaohong; Chen, Xi // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Highly active antiretroviral therapy (HAART) has significantly decreased mortality among Chinese HIV patients. However, emerging HIV drug resistance (HIVDR) poses a growing threat to the long-term success and durability of HAART. Methods: Three cross-sectional surveys were...

  • Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations. Bergeron, Michèle; Daneau, Géraldine; Ding, Tao; Sitoe, Nadia E.; Westerman, Larry E.; Stokx, Jocelijn; Jani, Ilesh V.; Coetzee, Lindi M.; Scott, Lesley; De Weggheleire, Anja; Boel, Luc; Stevens, Wendy S.; Glencross, Deborah K.; Peter, Trevor F.; Verhasselt, Bruno // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Introduction: Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentralization and reducing patient loss-to-follow-up. As new POC CD4 technologies become available, their performance should be assessed before widespread deployment. This study reports the findings...

  • The Cost of Managing HIV Infection in Highly Treatment-Experienced, HIV-Infected Adults in France. Colin, Xavier; Lafuma, Antoine; Costagliola, Dominique; Lang, Jean-Marie; Guillon, Pascal // PharmacoEconomics;2010 Supplement, Vol. 28, p59 

    Background: Highly active antiretroviral therapy (HAART) has greatly enhanced HIV management, lowering the risk of clinical disease progression and death by substantially improving HIV-induced immune deficiency. Lower CD4 cell counts have consistently been associated with higher direct costs of...

  • Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts: Evidence from POWER. Hill, Andrew M.; Gebo, Kelly; Hemmett, Lindsay; Löthgren, Mickael; Allegri, Gabriele; Smets, Erik // PharmacoEconomics;2010 Supplement, Vol. 28, p169 

    Background: Given the association between CD4 cell counts and HIV-related morbidity/mortality, new antiretroviral therapies could potentially lower the direct costs of HIV care by raising CD4 cell counts. Objectives: To predict the effects of the ritonavir-boosted, HIV protease inhibitor (PI)...

  • HIV: Getting to the bottom of CD4+ T-cell loss. Bird, Lucy // Nature Reviews Microbiology;Nov2004, Vol. 2 Issue 11, p853 

    The article cites the studies of two groups about the marked reduction of CD4+ T cells in the gastrointestinal tract on all stages of HIV infection, despite administration of highly active antiretroviral therapy (HAART). The group of Danny Douek studied T-cell depletion of untreated HIV-positive...

  • Leprosy occurring as immune reconstitution syndrome Deps, Patricia D.; Lockwood, Diana N.J. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2008, Vol. 102 Issue 10, p966 

    Summary: Immune reconstitution inflammatory syndrome (IRIS) may occur in HIV-infected patients after starting highly active antiretroviral therapy (HAART). Since 2003, 19 cases were published as IRIS. Leprosy has been reported as an example of an IRIS, and it is important that this syndrome...

  • Antiretrovirals in Pregnancy: A Note of Caution. Watts, D. Heather; Mofenson, Lynne M. // Journal of Infectious Diseases;Dec2012, Vol. 206 Issue 11, p1639 

    The author discusses maternal-to-child transmission (MTCT) of human immunodeficiency virus (HIV). He is critical of the antenatal highly active antiretroviral therapy (HAART) for all women regardless of maternal CD4+ cell count. He reflects to the guidelines issued by the World Health...

  • Sex Differences in HIV RNA Level and CD4 Cell Percentage During Childhood. Ruel, Theodore D.; Zanoni, Brian C.; Ssewanyana, Isaac; Cao, Huyen; Havlir, Diane V.; Kamya, Moses; Achan, Jane; Charlebois, Edwin D.; Feeney, Margaret E. // Clinical Infectious Diseases;9/15/2011, Vol. 53 Issue 6, p592 

    Background. HIV-infected women have lower HIV RNA levels and higher CD4-cell counts than do men. This observation has been attributed to the immunomodulatory effects of sex steroid hormones, such as estrogen and progesterone. Limited data exist regarding potential sex differences in HIV RNA...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics